相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes
Siva Koganti et al.
VIROLOGY (2020)
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
Jennifer L. Crombie et al.
FRONTIERS IN ONCOLOGY (2019)
PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Ling Ding et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Epstein–Barr Virus and Cancer
Paul J. Farrell
Annual Review of Pathology-Mechanisms of Disease (2018)
STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target
Erika Onozawa et al.
Oncotarget (2018)
SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair
Sharmistha Chakraborty et al.
ISCIENCE (2018)
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak et al.
NATURE GENETICS (2017)
Secondary structure forming sequences drive SD-MMEJ repair of DNA double-strand breaks
Varandt Y. Khodaverdian et al.
NUCLEIC ACIDS RESEARCH (2017)
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
Daniel J. McGrail et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
The biological effects and clinical implications of BRCA mutations: where do we go from here?
Dominique Stoppa-Lyonnet
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Polymerase θ is a robust terminal transferase that oscillates between three different mechanisms during end-joining
Tatiana Kent et al.
ELIFE (2016)
Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination
Pedro A. Mateos-Gomez et al.
NATURE (2015)
Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?
Agnel Sfeir et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
B Lymphocytes from Patients with a Hypomorphic Mutation in STAT3 Resist Epstein-Barr Virus-Driven Cell Proliferation
Siva Koganti et al.
JOURNAL OF VIROLOGY (2014)
STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation
Siva Koganti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer
Taofeek K. Owonikoko et al.
CANCER MEDICINE (2014)
Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
Johnathan A. Watkins et al.
BREAST CANCER RESEARCH (2014)
Signal Transducer and Activator of Transcription 3 Limits Epstein-Barr Virus Lytic Activation in B Lymphocytes
Erik R. Hill et al.
JOURNAL OF VIROLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies
Zeina Al-Mansour et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
Anneleen Daemen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication
Koji Nakanishi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A User's Guide to the Encyclopedia of DNA Elements (ENCODE)
Richard M. Myers et al.
PLOS BIOLOGY (2011)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond
Robert C. Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions
Amy Marie et al.
NUCLEIC ACIDS RESEARCH (2010)
Clinical Manifestations, Etiology, and Pathogenesis of the Hyper-IgE Syndromes
Alexandra F. Freeman et al.
PEDIATRIC RESEARCH (2009)
Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
J. Styczynski et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
David A. Thorley-Lawson et al.
NATURE REVIEWS MICROBIOLOGY (2008)
The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage
E. M. Bahassi et al.
ONCOGENE (2008)
Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair
Nicole Bennardo et al.
PLOS GENETICS (2008)
STAT3 mutations in the hyper-IgE syndrome
Steven M. Holland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
LH Chen et al.
EMBO JOURNAL (2005)
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
CS Sorensen et al.
NATURE CELL BIOLOGY (2005)
Post-transplant lymphoproliferative disorders
S Gottschalk et al.
ANNUAL REVIEW OF MEDICINE (2005)
Regularization and variable selection via the elastic net
H Zou et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2005)
Mechanisms of disease - Persistence of the Epstein-Barr virus and the origins of associated lymphomas
DA Thorley-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation
M Gatei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorder.
RR Nepomuceno et al.
TRANSPLANTATION (2002)
分享论文
